Bunazosin

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Bunazosin
Accession Number
DB12230
Type
Small Molecule
Groups
Investigational
Description

Bunazosin has been used in trials studying the treatment of High Blood Pressure.

Structure
Thumb
Synonyms
Not Available
Product Ingredients
IngredientUNIICASInChI Key
Bunazosin Hydrochloride18V54TZ7U652712-76-2NBGBEUITCPENLJ-UHFFFAOYSA-N
Categories
UNII
9UUW4V7G2H
CAS number
80755-51-7
Weight
Average: 373.457
Monoisotopic: 373.211389749
Chemical Formula
C19H27N5O3
InChI Key
RHLJLALHBZGAFM-UHFFFAOYSA-N
InChI
InChI=1S/C19H27N5O3/c1-4-6-17(25)23-7-5-8-24(10-9-23)19-21-14-12-16(27-3)15(26-2)11-13(14)18(20)22-19/h11-12H,4-10H2,1-3H3,(H2,20,21,22)
IUPAC Name
1-[4-(4-imino-6,7-dimethoxy-3,4-dihydroquinazolin-2-yl)-1,4-diazepan-1-yl]butan-1-one
SMILES
CCCC(=O)N1CCCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(=N)N1

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteraction
4-MethoxyamphetamineBunazosin may decrease the vasoconstricting activities of 4-Methoxyamphetamine.
AcebutololAcebutolol may increase the orthostatic hypotensive activities of Bunazosin.
AcepromazineBunazosin may increase the antihypertensive activities of Acepromazine.
AdrafinilBunazosin may decrease the vasoconstricting activities of Adrafinil.
AgmatineThe therapeutic efficacy of Agmatine can be decreased when used in combination with Bunazosin.
AlfuzosinAlfuzosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Bunazosin.
AlprenololAlprenolol may increase the orthostatic hypotensive activities of Bunazosin.
AmibegronBunazosin may decrease the vasoconstricting activities of Amibegron.
AmiodaroneThe risk or severity of hypotension can be increased when Bunazosin is combined with Amiodarone.
AmitrazBunazosin may decrease the vasoconstricting activities of Amitraz.
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Compound
2472
PubChem Substance
347828509
ChemSpider
2378
BindingDB
50088386
ChEBI
135576
ChEMBL
CHEMBL188185
Wikipedia
Bunazosin

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedTreatmentHigh Blood Pressure (Hypertension)1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.112 mg/mLALOGPS
logP1.44ALOGPS
logP1.12ChemAxon
logS-3.5ALOGPS
pKa (Strongest Acidic)12.72ChemAxon
pKa (Strongest Basic)5.83ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area90.25 Å2ChemAxon
Rotatable Bond Count5ChemAxon
Refractivity116.07 m3·mol-1ChemAxon
Polarizability40.54 Å3ChemAxon
Number of Rings3ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Taxonomy

Description
This compound belongs to the class of organic compounds known as quinazolinamines. These are heterocyclic aromatic compounds containing a quianazoline moiety substituted by one or more amine groups.
Kingdom
Organic compounds
Super Class
Organoheterocyclic compounds
Class
Diazanaphthalenes
Sub Class
Benzodiazines
Direct Parent
Quinazolinamines
Alternative Parents
Dialkylarylamines / Anisoles / Aminopyrimidines and derivatives / Alkyl aryl ethers / 1,4-diazepanes / Imidolactams / Tertiary carboxylic acid amides / Heteroaromatic compounds / Amino acids and derivatives / Azacyclic compounds
show 5 more
Substituents
Quinazolinamine / Anisole / Dialkylarylamine / 1,4-diazepane / Alkyl aryl ether / Diazepane / Aminopyrimidine / Pyrimidine / Benzenoid / Imidolactam
show 18 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
Not Available

Drug created on October 20, 2016 15:41 / Updated on August 02, 2018 06:35